Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2009-05-20

FDA Approved: ALDURAZYME — Supplemental Application (Genzyme Corporation)

View source ↗

Summary

FDA approved a supplemental application for ALDURAZYME (Laronidase) from Genzyme Corporation, updating aspects of the approved product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aldurazyme (Laronidase)

Snippet

SUPPL AP for ALDURAZYME (LARONIDASE)